Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: Gene-environment interaction and risk of prostate cancer

DNA and Cell Biology

Volumn 26, Issue 11, 2007, Pages 791-798

  Mittal, Rama D ^a   Srivastava, Dayashankar L ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; EPOXIDE HYDROLASE; GENOMIC DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; ENVIRONMENT; EXON; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING;

AGE FACTORS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EPOXIDE HYDROLASES; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSOMES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING;

NICOTIANA TABACUM;

EID: 36248970167     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0630     Document Type: Article

References (32)

1. Acevedo, C., Opazo, J.L., Huidobro, C.J., Cabezas, J., Iturrieta, L., and Sepulveda, Q. (2003). Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 57, 111-117.
2. Agundez, J.A.G., Martinez, C., Olivera, M., Gallardo, L., Ladero, J.M., Rosado, C., Prados, J., Rodrigues-Molina, J., Resel, L., and Benitez, J. (1998). Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk. Br J Cancer 78, 1361-1367.
3. Bale, A.E., Nebert, D.W., and McBride, O.W. (1987). Subchromosomal localization of the dioxin-inducible P1450 locus (CYP1) and description of two RFLPs detected within a 3′ P1450 cDNA probe. Cytogenet Cell Genet 46, 574-575.
4. Casson, A.G., Zheng, Z., Chiasson, D., MacDonald, K., Riddell, D.C., Guernsey, J.R., Guernsey, D.L., and McLaughlin, J. (2003). Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 27, 139-146.
5. Chang, B.L., Zheng, S.L., Isaacs, S.D., Turner, A., Hawkins, G.A., Wiley, K.E., Bleecker, E.R., Walsh, P.C., Meyers, D.A., Isaacs, W.B., and Xu, J. (2003). Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 106, 375-378.
6. Chen, S., Xue, L., Xu, G., Ma, J., and Wu, J. (2001). Polymorphism of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res 458, 41-47.
7. Figer, A., Friedman, T., Manguoglu, A.E., Flex, D., Vazina, A., Novikov, I., Shtrieker, A., Sidi, A.A., Tichler, T., Sapir, E.E., Baniel, J., and Friedman, E. (2003). Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. Isr Med Assoc J 5, 741-745.
8. Gsur, A., Zidek, T., Schnattinger, K., Feik, E., Haidinger, G., Hollaus, P., Mohn-Staudner, A., Armbruster, C., Madersbacher, S., Schatzl, G., Trieb, K., Vutuc, C., and Micksche, M. (2003). Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 89, 702-706.
9. Hassett, C., Aicher, L., Sidhu, J.S., and Omiecinski, C.J. (1994). Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3, 421-428.
10. Hsing, A.W., and Chokkalingam, A.P. (2006). Prostate cancer epidemiology. Front Biosci 11, 1388-1413.
11. Huang, W.Y., Chatterjee, N., Chanock, S., Dean, M., Yeager, M., Schoen, R.E., Hou, L.F., Berndt, S.I., Yadavalli, S., Johnson, C.C., and Hayes, R.B. (2005). Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14, 152-157.
12. Ingelman-Sundberg, M. (2004). Human drug metabolizing cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369, 89-104.
13. Jacquet, M., Lambert, V., Baudoux, E., Muller, M., Kremers, P., and Gielen, J. (1996). Correlation between P450 inducibility, Msp1 genotype and lung cancer incidence. Eur J Cancer 32, 1701-1706.
14. Jourenkova-Mironova, N., Mitrunen, K., Bouchardy, C., Dayer, P., Benhamou, S., and Hirvonen, A. (2000). High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 60, 534-536.
15. Lancaster, J.M., Browniee, H.A., Bell, D.A., Futreal, A., Marks, J.R., Berchuck, A., Wiseman, R.W., and Taylor, J.A. (1996). Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17, 160-162.
16. McGlynn, K.A., Rosvold, E.A., Lustbader, E.D., Hu, Y., Clapper, M.L., Zhou, T., Wild, C.P., Xia, X.L., Baffoe-Bonnie, A., Ofori Adjei, D., Chen, G.C., London, W.T., Shen, F.M., and Beutow, K.H. (1995). Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92, 2384-2387.
17. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
18. Mittal, R.D., Srivastava, D.S., Kumar, A., and Mittal, B. (2004). Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India. Indian J Cancer 41, 115-119.
19. Pastorelli, R., Guanci, M., Cerri, A., Negri, E., La Vecchia, C., Fumagalli, F., Mezzetti, M., Cappelli, R., Panigalli, T., Fanelli, R., and Airoldi, L. (1998). Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol Biomarkers Prev 7, 703-709.
20. Quinones, L.A., Irarrazabal, C.E., Rojas, C.R., Orellana, C.E., Acevedo, C., Huidobro, C., Varela, N.E., and Caceres, D.D. (2006). Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J Androl 8, 349-355.
21. Rodriguez, C., Tatham, L.M., Thun, M.J., Calle, E.E., and Health, C., Jr. (1997). Smoking and fatal prostate cancer in a large cohort of adult man. Am J Epidemiol 145, 466-475.
22. Salama, C.H., Sierra-Torres, H.Y., Oh, F.A., Hamada, F.A., and Au, W.W. (2001). Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ Mol Mutagen 37, 17-26.
23. Silig, Y., Pinarbasi, H., Gunes, S., Ayan, S., Bagci, H., and Cetinkaya, O. (2006). Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest 24, 41-45.
24. Sinha, R., Anderson, D.E., McDonald, S.S., and Greenwald, P. (2003). Cancer risk and diet in India. J Postgrad Med 49, 222-228.
25. Smith, C.A., and Harrison, D.J. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350, 630-633.
26. Spurr, N.K., Gough, A.C., Stevenson, K., and Wolf, C.R. (1987). Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 15, 5901-5907.
27. Srivastava, D.S., and Mittal, R.D. (2005). Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in North Indian population. BMC Urol 5, 1-6.
28. Sterling, K.M., Jr., and Cutroneo, K.R. (2004). Constitutive and inducible expression of cytochromes P4501A (CYP1A1 and CYP1A2) in normal prostate and prostate cancer cells. J Cell Biochem 91, 423-429.
29. Suzuki, K., Matsui, H., Nakazato, H., Koike, H., Okugi, H., Hasumi, M., Ohtake, N., Nakata, S., Takei, T., Hatori, M., Ito, K., and Yamanaka, H. (2003). Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study. Cancer Lett 195, 177-183.
30. Ulrich, C.M., Bigler, J., Whitton, J.A., Bostick, R., Fosdick, L., and Potter, J.D. (2001). Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10, 875-882.
31. Wang, L.D., Zheng, S., Liu, B., Zhou, J.X., Li, Y.J., and Li, J.X. (2003). CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China. World J Gastroenterol 9, 1394-1397.
32. Yang, J., Qian, L.X., Wu, H.F., Xu, Z.Q., Sui, Y.G., Wang, X.R., and Zhang, W. (2006). Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China. Int J Urol 13, 773-780.